What is Coherus Oncology, Inc. Common Stock's Market Cap?

Coherus Oncology, Inc. Common Stock's Market Cap is $207.0M, based on as-reported figures from SEC (XBRL) filings.

What is Coherus Oncology, Inc. Common Stock's Price / Sales?

Coherus Oncology, Inc. Common Stock's Price / Sales is 4.1×, based on as-reported figures from SEC (XBRL) filings.

What is Coherus Oncology, Inc. Common Stock's Revenue (TTM)?

Coherus Oncology, Inc. Common Stock's Revenue (TTM) is $50.9M, based on as-reported figures from SEC (XBRL) filings.

What is Coherus Oncology, Inc. Common Stock's Net Income (TTM)?

Coherus Oncology, Inc. Common Stock's Net Income (TTM) is -$132.1M, based on as-reported figures from SEC (XBRL) filings.

What is Coherus Oncology, Inc. Common Stock's EBITDA?

Coherus Oncology, Inc. Common Stock's EBITDA is -$155.1M, based on as-reported figures from SEC (XBRL) filings.

What is Coherus Oncology, Inc. Common Stock's Diluted EPS (TTM)?

Coherus Oncology, Inc. Common Stock's Diluted EPS (TTM) is -0.86, based on as-reported figures from SEC (XBRL) filings.

What is Coherus Oncology, Inc. Common Stock's EBITDA Margin?

Coherus Oncology, Inc. Common Stock's EBITDA Margin is -304.5%, based on as-reported figures from SEC (XBRL) filings.

Coherus Oncology, Inc. Common Stock (CHRS) Financial Statements

Coherus Oncology, Inc. Common Stock

SIC 2836 · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

FIGI BBG0063N8V87

XNAS · usd

1.34▼ 0.03 (-2.19%)

As of 2026-09-09

Valuation

Market Cap

Enterprise Value—

Trailing P/E—

Price / Sales

EV / Revenue—

EV / EBITDA—

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin

Net Debt—

Trading Information

Previous Close1.37

Day's Range1.36 – 1.43

52-Week Range1.09 – 2.62

Volume547.5K

Avg Volume1.1M

Share Statistics

Shares Outstanding

Employees147

ExchangeXNAS

Listed2014-11-06

Share count as of July 31, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Coherus Oncology, Inc. Common Stock (CHRS)

What is Coherus Oncology, Inc. Common Stock's Market Cap?: Coherus Oncology, Inc. Common Stock's Market Cap is $207.0M, based on as-reported figures from SEC (XBRL) filings.
What is Coherus Oncology, Inc. Common Stock's Price / Sales?: Coherus Oncology, Inc. Common Stock's Price / Sales is 4.1×, based on as-reported figures from SEC (XBRL) filings.
What is Coherus Oncology, Inc. Common Stock's Revenue (TTM)?: Coherus Oncology, Inc. Common Stock's Revenue (TTM) is $50.9M, based on as-reported figures from SEC (XBRL) filings.
What is Coherus Oncology, Inc. Common Stock's Net Income (TTM)?: Coherus Oncology, Inc. Common Stock's Net Income (TTM) is -$132.1M, based on as-reported figures from SEC (XBRL) filings.
What is Coherus Oncology, Inc. Common Stock's EBITDA?: Coherus Oncology, Inc. Common Stock's EBITDA is -$155.1M, based on as-reported figures from SEC (XBRL) filings.
What is Coherus Oncology, Inc. Common Stock's Diluted EPS (TTM)?: Coherus Oncology, Inc. Common Stock's Diluted EPS (TTM) is -0.86, based on as-reported figures from SEC (XBRL) filings.
What is Coherus Oncology, Inc. Common Stock's EBITDA Margin?: Coherus Oncology, Inc. Common Stock's EBITDA Margin is -304.5%, based on as-reported figures from SEC (XBRL) filings.